Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Rae

Showing results (111-120 of 167) with videos related to

Pageof 17
Sort By:
The Journal of Infectious Diseases|April 1, 1997
A pilot study of hydroxyurea among patients with advanced human immunodeficiency virus (HIV) disease receiving chronic didanosine therapy: Canadian HIV trials network protocol 080J S Montaner, C Zala, B Conway, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 19, 2000
Meta-analysis of two randomized controlled trials comparing combined zidovudine and didanosine therapy with combined zidovudine, didanosine, and nevirapine therapy in patients with HIV. INCAS study teamJ M Raboud, S Rae, S Vella, et al.
Journal of Psychopharmacology (Oxford, England)|June 23, 2011
Clinically unintended medication switches and inability to prescribe preferred medications under Medicare Part DJoyce C West, Donald S Rae, Ramin Mojtabai, et al.
Social Psychiatry and Psychiatric Epidemiology|November 1, 1990
Phobia: prevalence and risk factorsJ H Boyd, D S Rae, J W Thompson, et al.
Psychiatric Services (Washington, D.C.)|July 4, 2013
Sustaining practice change one year after completion of the national depression management leadership initiativeHenry Chung, Farifteh Firoozmand Duffy, David J Katzelnick, et al.
Archives of General Psychiatry|March 7, 1998
Limitations of diagnostic criteria and assessment instruments for mental disorders. Implications for research and policyD A Regier, C T Kaelber, D S Rae, et al.
The Journal of Infectious Diseases|November 14, 1997
Stavudine plus lamivudine in advanced human immunodeficiency virus disease: a short-term pilot studyD Rouleau, B Conway, J Raboud, et al.
The Journal of Nervous and Mental Disease|April 1, 1997
Sociodemographic factors and prevalence rates of mental illness in Germany and the United StatesM M Fichter, W Narrow, M Roper, et al.
The Journal of Infectious Diseases|February 11, 2000
Human immunodeficiency virus-infected persons with mutations conferring resistance to zidovudine show reduced virologic responses to hydroxyurea and stavudine-lamivudineJ S Montaner, T Mo, J M Raboud, et al.
Plos One|November 3, 2020
Bridging of nucleosome-proximal DNA double-strand breaks by PARP2 enhances its interaction with HPF1Guillaume Gaullier, Genevieve Roberts, Uma M Muthurajan, et al.
Pageof 17

Showing results (111-120 of 167) with videos related to

Sort By:
Pageof 17
The Journal of Infectious Diseases|April 1, 1997
A pilot study of hydroxyurea among patients with advanced human immunodeficiency virus (HIV) disease receiving chronic didanosine therapy: Canadian HIV trials network protocol 080J S Montaner, C Zala, B Conway, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 19, 2000
Meta-analysis of two randomized controlled trials comparing combined zidovudine and didanosine therapy with combined zidovudine, didanosine, and nevirapine therapy in patients with HIV. INCAS study teamJ M Raboud, S Rae, S Vella, et al.
Journal of Psychopharmacology (Oxford, England)|June 23, 2011
Clinically unintended medication switches and inability to prescribe preferred medications under Medicare Part DJoyce C West, Donald S Rae, Ramin Mojtabai, et al.
Social Psychiatry and Psychiatric Epidemiology|November 1, 1990
Phobia: prevalence and risk factorsJ H Boyd, D S Rae, J W Thompson, et al.
Psychiatric Services (Washington, D.C.)|July 4, 2013
Sustaining practice change one year after completion of the national depression management leadership initiativeHenry Chung, Farifteh Firoozmand Duffy, David J Katzelnick, et al.
Archives of General Psychiatry|March 7, 1998
Limitations of diagnostic criteria and assessment instruments for mental disorders. Implications for research and policyD A Regier, C T Kaelber, D S Rae, et al.
The Journal of Infectious Diseases|November 14, 1997
Stavudine plus lamivudine in advanced human immunodeficiency virus disease: a short-term pilot studyD Rouleau, B Conway, J Raboud, et al.
The Journal of Nervous and Mental Disease|April 1, 1997
Sociodemographic factors and prevalence rates of mental illness in Germany and the United StatesM M Fichter, W Narrow, M Roper, et al.
The Journal of Infectious Diseases|February 11, 2000
Human immunodeficiency virus-infected persons with mutations conferring resistance to zidovudine show reduced virologic responses to hydroxyurea and stavudine-lamivudineJ S Montaner, T Mo, J M Raboud, et al.
Plos One|November 3, 2020
Bridging of nucleosome-proximal DNA double-strand breaks by PARP2 enhances its interaction with HPF1Guillaume Gaullier, Genevieve Roberts, Uma M Muthurajan, et al.
Pageof 17